Metacare
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Metacare is an industrials company listed on KOSPI, South Korea's main stock exchange, operating in the machinery, capital goods, and commercial services space.
The filing's table of contents outlines standard Korean disclosure sections, covering products, raw materials, production facilities, and sales, but does not provide sufficient detail in the excerpt provided to identify a specific flagship product or primary customer group. Based on available information, the company distributes or trades industrial goods, though the precise product lines and supply-chain position cannot be confirmed from the filing text alone.
Summary is AI-generated and may contain errors · figures from DART filings
Metacare in five facts
What does Metacare do?
Metacare is an industrials company listed on KOSPI, South Korea's main stock exchange, operating in the machinery, capital goods, and commercial services space.
Where is Metacare listed and in which sector?
Metacare (Korean name: 메타케어) trades under KRX code 118000 on KOSPI, the main board of the Korea Exchange. It is classified in the Industrials sector, Trading & Distribution.
How large is Metacare?
Its market capitalisation was US$20.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Metacare's latest annual revenue and operating profit?
For fiscal year 2025, Metacare reported revenue of US$24.8M, operating profit of US$999.9K and a net loss of US$160K, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 62.4% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- DisclosureOct 21
- DisclosureOct 21
- Completion report on merger, etc. (merger)
Metacare Co., Ltd. completed its small-scale absorption merger of wholly owned subsidiary JK Medi Co., Ltd. effective October 1, 2026, with a merger ratio of 1:0 and no new shares issued; 330 shareholders filed objections covering 313,436 shares (1.42% of total issued shares), and no creditor objections were received.
M&A · Oct 1 - Material event report (decision to redeem own convertible bonds early)Capital raise · Sep 28
- [Attachment amended] Material event report (merger)M&A · Jul 29
- Material event report (merger)
Metacare's board decided on July 28, 2026 to absorb its wholly owned subsidiary JK Medi Co., Ltd. in a no-new-shares small-scale merger (merger ratio 1.0000000 : 0.0000000), with a merger date of October 1, 2026, to strengthen business competitiveness; JK Medi reported 2025 revenue of US$2.61M and net income of US$225K.
M&A · Jul 28 - Decision to acquire shares/equity in another company
Metacare disclosed an acquisition of Tech Labs Co., Ltd., worth US$7.13M.
M&A · Jun 29 - [Amended] Material event report (rights offering)
Metacare updated the terms of a private placement (third-party allotment) to raise US$3.89M, about 22.6% of its market value.
Capital raise · Jun 29 - Results of rights offering or equity-linked bond issuance (voluntary)Capital raise · Jun 18
- Material event report (rights offering)
Metacare disclosed a private placement (third-party allotment) to raise US$3.93M, about 22.6% of its market value.
Capital raise · Jun 9 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Metacare updated its previously filed consolidated results for FY2025: revenue of US$21.9M (+62.42% year on year), operating profit of US$882K (−11.97% year on year) and a net loss of US$141K (from a profit a year earlier).
Earnings · Mar 16 · 2 versions